Predicting the risk of coronary heart disease with conventional, genetic and novel molecular biomarkers aims to answer three major questions for those seeking an evidence-based approach for assessing individual risk of coronary heart disease:

  1. How should risk be assessed?
  2. Which biomarkers should be incorporated into risk assessment?
  3. Can genetic information improve risk prediction?

The report goes on to explore the implications of its findings for the appraisal and use of biomarkers more generally.

How to reference this report: Predicting the risk of coronary heart disease with conventional, genetic and novel molecular biomarkers. Dent, T. PHG Foundation (2010). ISBN 978-1-907198-02-1

This work has been accepted for publication in modified form in Atherosclerosis.

For further information about the report, please contact Dr Tom Dent.

For members of the media, quotations and contact details for authors and relevant experts are available; please contact the PHG Foundation press office on 07505092081.